Oramed Pharmaceuticals
ORMP
#9136
Rank
$0.11 B
Marketcap
$2.90
Share price
8.21%
Change (1 day)
15.54%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): -$4.24 Million USD

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are $2 Million USD. In 2024 the company made an earning of $0.35 Million USD a decrease over its 2023 earnings that were of $7.12 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$4.24 Million-1300.57%
2024 $0.35 M-95.05%
2023 $7.12 M-119.45%
2022 -$36.63 Million39.17%
2021 -$26.32 Million73.93%
2020 -$15.14 Million18.53%
2019 -$12.77 Million-16.62%
2018 -$15.32 Million38.32%
2017 -$11.07 Million12.51%
2016 -$9.84 Million25.01%
2015 -$7.87 Million18.18%
2014 -$6.66 Million39.72%
2013 -$4.77 Million46.4%
2012 -$3.26 Million128.32%
2011 -$1.43 Million-51.47%
2010 -$2.94 Million35.21%
2009 -$2.18 Million
2007 -$3.42 Million607.04%
2006 -$0.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-$0.52 Billion 12,138.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
$20.84 B-491,978.24%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
$9.10 B-214,830.06%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-$27.57 Million 550.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-$68.58 Million 1,518.17%๐Ÿ‡บ๐Ÿ‡ธ USA